市場調查報告書

卵巢癌治療藥的全球市場:2020年

Ovarian Cancer Drugs Global Market Report 2020

出版商 The Business Research Company 商品編碼 918136
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
卵巢癌治療藥的全球市場:2020年 Ovarian Cancer Drugs Global Market Report 2020
出版日期: 2019年12月09日內容資訊: 英文
簡介

本報告提供全球卵巢癌治療藥市場相關調查分析,市場特徵,市場規模與成長率,市場區隔,各地區、國家分析,競爭情形,市場佔有率,趨勢,策略等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 市場特徵

第3章 市場規模與成長

  • 市場成果,2015年∼2019年(10億美元)
    • 市場成長要素
    • 市場阻礙因素
  • 市場預測,2019年∼2022年,2025年,2030年(10億美元)
    • 市場成長要素
    • 市場阻礙因素

第4章 市場區隔

  • 各腫瘤類型市場,成果及預測,2015年∼2019年,2022年,2025年,2030年(10億美元)
    • 表皮性卵巢癌
    • 卵巢低惡性腫瘤
    • 生殖細胞腫瘤
    • 性繩索間品質腫瘤
  • 各流通管道市場,成果及預測,2015年∼2019年,2022年,2025年,2030年(10億美元)
    • 醫院藥局
    • 藥妝店
    • 其他
  • 各治療藥類型市場,成果及預測,2015年∼2019年,2022年,2025年,2030年(10億美元)
    • 烷化劑
    • 有絲分裂抑制劑
    • 抗風濕藥
    • 抗乾癬藥
    • VEGF / VEGFR抑制劑
    • PARP抑制劑
    • 抗癌藥物
    • 其他

第5章 地區以及各國分析

  • 各地區市場,成果及預測,2015年∼2019年,2022年,2025年,2030年(10億美元)
  • 各國市場,成果及預測,2015年∼2019年,2022年,2025年,2030年(10億美元)

第6章 亞太地區市場

  • 市場概要
  • 各腫瘤類型市場,成果及預測,2015年∼2019年,2022年,2025年,2030年(10億美元)
  • 各流通管道市場,成果及預測,2015年∼2019年,2022年,2025年,2030年(10億美元)
  • 各治療藥類型市場,成果及預測,2015年∼2019年,2022年,2025年,2030年(10億美元)

第7章 中國市場

第8章 印度市場

第9章 日本市場

第10章 澳洲市場

第11章 印尼市場

第12章 韓國市場

第13章 西歐市場

第14章 英國市場

第15章 德國市場

第16章 法國市場

第17章 東歐市場

第18章 俄羅斯市場

第19章 北美市場

第20章 美國市場

第21章 南美市場

第22章 巴西市場

第23章 中東市場

第24章 非洲市場

第25章 市場競爭形勢及企業簡介

  • 市場競爭環境
  • 企業概要
    • AstraZeneca
    • Roche
    • Tesaro
    • Clovis Oncology
    • Boehringer Ingelheim

第26章 市場上主要的收購與合併

第27章 市場趨勢與策略

第28章 產品平台分析

第29章 市場未來展望與潛在力分析

第30章 附錄

  • 簡稱
  • 貨幣
  • 調查相關諮詢方式
  • The Business Research Company
  • 著作權及免責聲明
目錄

Ovarian Cancer Drugs Market Global Report 2020 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global ovarian cancer drugs market.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the ovarian cancer drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Ovarian Cancer Drugs Market Global Report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.

  • The Market Characteristics section of the report defines and explains the market.
  • The Market Size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market Segmentations break down market into sub markets.
  • The Regional and Country section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive Landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The Trends and Strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.

Scope

Markets Covered: 1) By Tumor Type: Epithelial Ovarian Cancer, Ovarian Low Malignant Potential Tumor, Germ Cell Tumor, Sex Cord-Stromal Tumor 2) By Distribution Channel: Hospital Pharmacies, Drug Stores, Others 3) By Drug Type: Alkylating Agents, Mitotic Inhibitors, Antirheumatics, Antipsoriatics, VEGF/VEGFR inhibitors, PARP inhibitors, Antineoplastics, Others

Companies Mentioned: AstraZeneca, Roche, Tesaro, Clovis Oncology, Boehringer Ingelheim

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time Series: Five years historic and forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Ovarian Cancer Drugs Market Characteristics

3. Ovarian Cancer Drugs Market Size And Growth

  • 3.1. Global Ovarian Cancer Drugs Historic Market, 2015 - 2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Ovarian Cancer Drugs Forecast Market, 2019 - 2022F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Ovarian Cancer Drugs Market Segmentation

  • 4.1. Global Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
    • Epithelial Ovarian Cancer
    • Ovarian Low Malignant Potential Tumor
    • Germ Cell Tumor
    • Sex Cord-Stromal Tumor
  • 4.2. Global Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
    • Hospital Pharmacies
    • Drug Stores
    • Others
  • 4.3. Global Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
    • Alkylating Agents
    • Mitotic Inhibitors
    • Antirheumatics
    • Antipsoriatics
    • VEGF/VEGFR inhibitors
    • PARP inhibitors
    • Antineoplastics
    • Others

5. Ovarian Cancer Drugs Market Regional And Country Analysis

  • 5.1. Global Ovarian Cancer Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 5.2. Global Ovarian Cancer Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

6. Asia-Pacific Ovarian Cancer Drugs Market

  • 6.1. Asia-Pacific Ovarian Cancer Drugs Market Overview
  • 6.2. Asia-Pacific Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 6.3. Asia-Pacific Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 6.4. Asia-Pacific Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

7. China Ovarian Cancer Drugs Market

  • 7.1. China Ovarian Cancer Drugs Market Overview
  • 7.2. China Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
  • 7.3. China Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
  • 7.4. China Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion

8. India Ovarian Cancer Drugs Market

  • 8.1. India Ovarian Cancer Drugs Market Overview
  • 8.2. India Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 8.3. India Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 8.4. India Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

9. Japan Ovarian Cancer Drugs Market

  • 9.1. Japan Ovarian Cancer Drugs Market Overview
  • 9.2. Japan Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 9.3. Japan Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 9.4. Japan Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

10. Australia Ovarian Cancer Drugs Market

  • 10.1. Australia Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 10.2. Australia Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 10.3. Australia Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

11. Indonesia Ovarian Cancer Drugs Market

  • 11.1. Indonesia Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 11.2. Indonesia Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 11.3. Indonesia Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

12. South Korea Ovarian Cancer Drugs Market

  • 12.1. South Korea Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 12.2. South Korea Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 12.3. South Korea Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

13. Western Europe Ovarian Cancer Drugs Market

  • 13.1. Western Europe Ovarian Cancer Drugs Market Overview
  • 13.2. Western Europe Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 13.3. Western Europe Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 13.4. Western Europe Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

14. UK Ovarian Cancer Drugs Market

  • 14.1. UK Ovarian Cancer Drugs Market Overview
  • 14.2. UK Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 14.3. UK Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 14.4. UK Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

15. Germany Ovarian Cancer Drugs Market

  • 15.1. Germany Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 15.2. Germany Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 15.3. Germany Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

16. France Ovarian Cancer Drugs Market

  • 16.5. France Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 16.6. France Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 16.7. France Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

17. Eastern Europe Ovarian Cancer Drugs Market

  • 17.1. Eastern Europe Ovarian Cancer Drugs Market Overview
  • 17.2. Eastern Europe Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 17.3. Eastern Europe Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 17.4. Eastern Europe Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

18. Russia Ovarian Cancer Drugs Market

  • 18.1. Russia Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 18.2. Russia Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 18.3. Russia Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

19. North America Ovarian Cancer Drugs Market

  • 19.1. North America Ovarian Cancer Drugs Market Overview
  • 19.2. North America Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 19.3. North America Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 19.4. North America Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

20. USA Ovarian Cancer Drugs Market

  • 20.1. USA Ovarian Cancer Drugs Market Overview
  • 20.2. USA Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 20.3. USA Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 20.4. USA Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

21. South America Ovarian Cancer Drugs Market

  • 21.1. South America Ovarian Cancer Drugs Market Overview
  • 21.2. South America Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 21.3. South America Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 21.4. South America Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

22. Brazil Ovarian Cancer Drugs Market

  • 22.1. Brazil Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 22.2. Brazil Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 22.3. Brazil Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

23. Middle East Ovarian Cancer Drugs Market

  • 23.1. Middle East Ovarian Cancer Drugs Market Overview
  • 23.2. Middle East Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 23.3. Middle East Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 23.4. Middle East Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

24. Africa Ovarian Cancer Drugs Market

  • 24.1. Africa Ovarian Cancer Drugs Market Overview
  • 24.2. Africa Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 24.3. Africa Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 24.4. Africa Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

25. Ovarian Cancer Drugs Market Competitive Landscape And Company Profiles

  • 25.1. Ovarian Cancer Drugs Market Competitive Landscape
  • 25.2. Ovarian Cancer Drugs Market Company Profiles
    • 25.2.1. AstraZeneca
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. Roche
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. Tesaro
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Clovis Oncology
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. Boehringer Ingelheim
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Ovarian Cancer Drugs Market

27. Ovarian Cancer Drugs Market Trends And Strategies

28. Product Pipeline Analysis

29. Ovarian Cancer Drugs Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Research Inquiries
  • 30.4. The Business Research Company
  • 30.5. Copyright And Disclaimer